恶性胸腔积液胸水细胞学诊断敏感性:系统综述与荟萃分析
BACKGROUND: Pleural fluid cytology is an important diagnostic test used for the investigation of pleural effusions. There is considerable variability in the reported sensitivity for the diagnosis of malignant pleural effusions (MPE) in the literature.…
要点
- 胸水细胞学诊断MPE总体敏感性仅58.2%,阴性结果不能排除恶性。
- 肺腺癌敏感性83.6%,肺鳞癌24.2%,间皮瘤28.9%。
- 卵巢癌敏感性85.2%,乳腺癌65.3%。
核心结论
- 胸水细胞学诊断恶性胸腔积液的总体敏感性为58.2%(95%CI 52.5%–63.9%)。
- 临床医生应知晓不同原发肿瘤类型的诊断敏感性差异很大,以及假阴性细胞学结果的潜在原因。
研究设计与样本
- 系统综述与荟萃分析,检索EMBASE和MEDLINE,由四名评价者完成。
- 使用二分类随机效应模型确定汇总敏感性,并按原发肿瘤部位进行亚组分析、按发表年份进行meta回归。
主要发现
- 胸水细胞学诊断MPE的总体敏感性为58.2%(95%CI 52.5%–63.9%;范围20.5%–86.0%)。
- 研究间存在显著异质性(I2 95.5%)。
- 原发性胸部恶性肿瘤中,肺腺癌敏感性最高(83.6%;95%CI 77.7%–89.6%),肺鳞癌最低(24.2%;95%CI 17.0%–31.5%),间皮瘤为28.9%(95%CI 16.2%–41.5%)。
- 肺外来源恶性肿瘤中,卵巢癌敏感性高(85.2%;95%CI 74.2%–96.1%),乳腺癌为65.3%(95%CI 49.8%–80.8%)。
关键数值与推荐
- 胸水细胞学诊断MPE总体敏感性58.2%(95%CI 52.5%–63.9%)。
- 肺腺癌敏感性83.6%(95%CI 77.7%–89.6%),肺鳞癌24.2%(95%CI 17.0%–31.5%),间皮瘤28.9%(95%CI 16.2%–41.5%)。
- 卵巢癌敏感性85.2%(95%CI 74.2%–96.1%),乳腺癌65.3%(95%CI 49.8%–80.8%)。
临床怎么用
- 胸水细胞学阴性不能排除恶性胸腔积液,需结合原发肿瘤类型判断验前概率。
- 对肺鳞癌或间皮瘤疑似患者,应知晓细胞学敏感性低,必要时考虑进一步检查。
局限性
- 研究间存在显著异质性(I2 95.5%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pleural fluid cytology is an important diagnostic test used for the investigation of pleural effusions. There is considerable variability in the reported sensitivity for the diagnosis of malignant pleural effusions (MPE) in the literature. OBJECTIVE: The purpose of this review is to determine the diagnostic sensitivity of pleural fluid cytology for MPE, both overall and by tumour type, to better inform the decision-making process when investigating pleural effusions. DATA SOURCES: A literature search of EMBASE and MEDLINE was performed by four reviewers. Articles satisfying inclusion criteria were evaluated for bias using the QUADAS-2 tool. DATA EXTRACTION: For quantitative analysis, we performed a metaanalysis using a binary random-effects model to determine pooled sensitivity. Subgroup analysis was performed based on primary cancer site and meta-regression by year of publication. SYNTHESIS: Thirty-six studies with 6057 patients with MPE were included in the meta-analysis. The overall diagnostic sensitivity of pleural fluid cytology for MPE was 58.2% (95% CI 52.5% to 63.9%; range 20.5%-86.0%). There was substantial heterogeneity present among studies (I2 95.5%). For primary thoracic malignancies, sensitivity was highest in lung adenocarcinoma (83.6%; 95% CI 77.7% to 89.6%) and lowest in lung squamous cell carcinoma (24.2%; 95% CI 17.0% to 31.5%) and mesothelioma (28.9%; 95% CI 16.2% to 41.5%). For malignancies with extrathoracic origin, sensitivity was high for ovarian cancer (85.2%; 95% CI 74.2% to 96.1%) and modest for breast cancer (65.3%; 95% CI 49.8% to 80.8%). CONCLUSIONS: Pleural fluid cytology has an overall sensitivity of 58.2% for the diagnosis of MPE. Clinicians should be aware of the high variability in diagnostic sensitivity by primary tumour type as well as the potential reasons for false-negative cytology results.PROSPERO registration numberCRD42021231473.
引用
- Kassirian S, Hinton SN, Cuninghame S, et al. Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis. Thorax. 2022. PMID: 35110369. doi:10.1136/thoraxjnl-2021-217959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。